NZ331264A - use of 1-aralkyl- 2-aryl substituted naphthyl derivatives in treating postmenopausal syndrome associated disorders, endometriosis or uterine fibroid disease - Google Patents

use of 1-aralkyl- 2-aryl substituted naphthyl derivatives in treating postmenopausal syndrome associated disorders, endometriosis or uterine fibroid disease

Info

Publication number
NZ331264A
NZ331264A NZ331264A NZ33126495A NZ331264A NZ 331264 A NZ331264 A NZ 331264A NZ 331264 A NZ331264 A NZ 331264A NZ 33126495 A NZ33126495 A NZ 33126495A NZ 331264 A NZ331264 A NZ 331264A
Authority
NZ
New Zealand
Prior art keywords
endometriosis
aralkyl
uterine fibroid
aryl substituted
substituted naphthyl
Prior art date
Application number
NZ331264A
Inventor
Henry Uhlman Bryant
George Joseph Cullinan
Jeffrey Alan Dodge
Kennan Joseph Fahey
Charles David Jones
Charles Willis Lugar
Brian Stephen Muehl
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/309,525 external-priority patent/US7501441B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ331264A publication Critical patent/NZ331264A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The naphthyl derivatives of formula I or a pharmaceutically acceptable salt thereof are used in the manufacture of a medicament for treating the symptoms of postmenopausal syndrome in women or for inhibiting uterine fibroid disease, aortal smooth muscle cell proliferation, restenosis or endometriosis in women. In formula I: R1 and R2 are independently H, OH, -O-alkyl, -OCO-phenyl, -OCO-alkyl, or -OSO2-alkyl; n is 2 or 3; R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholinyl, dimethylamino, diethylamino or 1-hexamethyleneimino.
NZ331264A 1994-09-20 1995-09-18 use of 1-aralkyl- 2-aryl substituted naphthyl derivatives in treating postmenopausal syndrome associated disorders, endometriosis or uterine fibroid disease NZ331264A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/309,525 US7501441B1 (en) 1994-09-20 1994-09-20 Naphthyl compounds, intermediates, processes, compositions, and methods
NZ294177A NZ294177A (en) 1994-09-20 1995-09-18 1-aralkyl-, 2-aryl-substituted naphthyl derivatives and pharmaceutical formulations

Publications (1)

Publication Number Publication Date
NZ331264A true NZ331264A (en) 2000-08-25

Family

ID=26651643

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ331264A NZ331264A (en) 1994-09-20 1995-09-18 use of 1-aralkyl- 2-aryl substituted naphthyl derivatives in treating postmenopausal syndrome associated disorders, endometriosis or uterine fibroid disease

Country Status (1)

Country Link
NZ (1) NZ331264A (en)

Similar Documents

Publication Publication Date Title
NZ294177A (en) 1-aralkyl-, 2-aryl-substituted naphthyl derivatives and pharmaceutical formulations
CA2228997A1 (en) Benzothiophene compounds
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
EP0976398A3 (en) Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
NZ212025A (en) 3-aminopyrazoles and pharmaceutical compositions
CY2599B2 (en) Benzothiophene formulations of a specific dosage
PL321498A1 (en) Pharmaceutic agent for use against urine incontinence and method of obtaining (s)-desethyloxybutinine
GB9423911D0 (en) Therapeutic agents
ES2010071A6 (en) Isoquinoline derivatives and their use
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
HUT62192A (en) Process for producing pharmaceutical compositions comprising tomoxetine and suitable for treating diseases of lower urinary tract
NZ270181A (en) Use of benzothiophene derivatives for inhibiting central nervous system problems in post-menopausal women
NZ315174A (en) Naphthyl and dihydronaphthyl compounds, pharmaceutical compositions and use thereof
TW349865B (en) Therapeutic agent for hemorrhoidal diseases
MXPA04000407A (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents.
MY113062A (en) Amide derivatives and their therapeutic use
NZ331264A (en) use of 1-aralkyl- 2-aryl substituted naphthyl derivatives in treating postmenopausal syndrome associated disorders, endometriosis or uterine fibroid disease
NO20031741D0 (en) Use of antiprogestins for induction of apoptosis in a cell
MY115619A (en) Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
YU29903A (en) Use of antiprogestins for the induction of apoptosis in a cell
IL126795A0 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
ES2086863T3 (en) N-AMINOALKYLMETANSULFANILIDES SUBSTITUTED AS ANTIESPASMODIC.
GEP19991747B (en) Tetrahydroisoquinolinylcarbamates of 1,2,3,3A,8,8A-Hexahydro-1,3A,8-Trimethylpyrrolo[2,3-B]Indole or Their Isomers or Their Pharmaceutically Acceptable Acid-Additive Salts, Pharmaceutical Composition Containing Them and Method for Treatment
IL101163A (en) Use of flunarizine in the preparation of medicaments for treating neoplastic diseases
HUP0104619A3 (en) Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases